EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Safety of Onabotulinumtoxin-A for Chronic Migraine During Pregnancy and Breastfeeding: A Narrative Review

Antonio Russo, Luigi Francesco Iannone iD, Ilaria Orologio, Veronica Rivi iD, Alberto Boccalini, Flavia Lo Castro iD, Marcello Silvestro, Simona Guerzoni iD

Toxins · 2025

DOI: 10.3390/toxins17040192 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Toxins, 2025. Verfasst von Antonio Russo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Antonio Russo Headache Center, Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy. Hauptthemen laut MEDLINE: Migraine Disorders, Botulinum Toxins, Type A, Breast Feeding, Neuromuscular Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Onabotulinumtoxin-A (onabotA) is a neurotoxin widely used for several indications, including chronic migraine (CM) preventive treatment, due to its well-demonstrated efficacy, tolerability, and safety. However, onabotA safety during pregnancy and breastfeeding remains unclear, as these populations are typically excluded from clinical trials. The action of onabotA starts locally at the injection sites, modulating the pain pathway with minimal systemic absorption, which theoretically minimizes risks to the fetus or breastfeeding infant. Preclinical studies demonstrate that onabotA does not distribute systemically in significant amounts after administration, although adverse fetal outcomes in rats and rabbits were reported when injected at high doses. Limited human data suggest that onabotA exposure during pregnancy may not be associated with major malformations or significant adverse outcomes for the fetus, especially when used at therapeutic doses for migraine prevention during the first trimester or earlier. Data on breastfeeding are even scarcer but indicate a low likelihood of drug transfer into breast milk. This narrative review highlights the available evidence on the use of onabotA in pregnancy and breastfeeding women, including real-word evidence, with a focus on the use for CM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Migraine DisordersBotulinum Toxins, Type ABreast FeedingNeuromuscular AgentsPregnancy ComplicationsHumansPregnancyFemaleAnimalsChronic DiseaseMilk, Human

Stichwörter der Autor:innen

Onabotulinumtoxin-Abreastfeedingchronic migrainefetal outcomespregnancysafety

Substanzen

Botulinum Toxins, Type Aonabotulinum toxin ANeuromuscular Agents

Autor:innen und Institutionen

  • Antonio Russo Headache Center, Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.
  • MRI Research Center SUN-FISM, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.
  • Digital and Predictive Medicine, Pharmacology and Clinical Metabolic Toxicology-Headache Center and Drug Abuse-Laboratory of Clinical Pharmacology and Pharmacogenomics, AOU Policlinico Di Modena, 41124 Modena, Italy.
  • Department of Biomedical, Metabolic, and Neuroscience Science, University of Modena and Reggio Emilia, 41125 Modena, Italy.

ORCID-Profile: Luigi Francesco Iannone, Veronica Rivi, Flavia Lo Castro, Simona Guerzoni

Zitieren

APA

Russo, A., Iannone, L. F., Orologio, I., Rivi, V., Boccalini, A., Lo Castro, F., Silvestro, M., & Guerzoni, S. (2025). Safety of Onabotulinumtoxin-A for Chronic Migraine During Pregnancy and Breastfeeding: A Narrative Review. Toxins. https://doi.org/10.3390/toxins17040192

Vancouver

Russo A, Iannone LF, Orologio I, Rivi V, Boccalini A, Lo Castro F, et al. Safety of Onabotulinumtoxin-A for Chronic Migraine During Pregnancy and Breastfeeding: A Narrative Review. Toxins. 2025. doi:10.3390/toxins17040192

BibTeX
@article{Russo2025,
  author = {Russo, Antonio and Iannone, Luigi Francesco and Orologio, Ilaria and Rivi, Veronica and Boccalini, Alberto and Lo Castro, Flavia and Silvestro, Marcello and Guerzoni, Simona},
  title = {Safety of Onabotulinumtoxin-A for Chronic Migraine During Pregnancy and Breastfeeding: A Narrative Review},
  journal = {Toxins},
  year = {2025},
  doi = {10.3390/toxins17040192}
}
Kostenlos starten →